Trial Profile
Fifteen Year Follow-up to Evaluate Long-term Effectiveness of VARIVAX Among Children and Adolescents.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 02 Nov 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 03 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 03 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.